TMED vs. IDNA
TMED (T. Rowe Price Health Care ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds. A 0.79 correlation means they provide meaningful diversification when combined. TMED charges 0.44%/yr vs 0.47%/yr for IDNA.
Performance
TMED vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 3.87% return, which is significantly lower than IDNA's 10.31% return.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- 0.73%
- 1M
- -2.56%
- YTD
- 10.31%
- 6M
- 8.52%
- 1Y
- 40.87%
- 3Y*
- 6.74%
- 5Y*
- -8.42%
- 10Y*
- —
TMED vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.31% | 23.44% |
Correlation
The correlation between TMED and IDNA is 0.79, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.79 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. IDNA — Risk / Return Rank
TMED
IDNA
TMED vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.68 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | 0.10 | +1.25 |
Drawdowns
TMED vs. IDNA - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for TMED and IDNA.
Loading charts...
Drawdown Indicators
| TMED | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -68.26% | +57.15% |
Max Drawdown (1Y)Largest decline over 1 year | — | -10.66% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -29.73% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -2.75% | -45.61% | +42.86% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -36.24% | +33.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.73% | — |
Volatility
TMED vs. IDNA - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.18% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 17.98% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 24.48% | -6.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 28.42% | -10.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 29.53% | -11.49% |
TMED vs. IDNA - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
TMED vs. IDNA - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, less than IDNA's 1.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.07% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and IDNA have a correlation of 0.79, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 1.07%, compared with 0.52% for TMED.
They also come from different issuers: T. Rowe Price and iShares. Their fees differ too: 0.44% for TMED and 0.47% for IDNA.
Find the right allocation for TMED and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer